Laboratory Innovation New

6.5 CME Credits

5 February 2020
Dubai World Trade Centre

The conference will discuss what technology and innovation have to offer for future in the lab. Lab Innovation Conference will feature discussions on stem cells, AI, VR, advanced mass spectrometry, novel biomarkers, next generation sequencing and their actual application and implementation in diagnostics. Along with the great potential to improve working efficiency, patient care and experience, adaptation and implementation..


Key topics:

  • CRISPR
  • AI, VR and digital transformation
  • POCT and IOT
  • Medical solutions stemming from stem cells 
  • Novel biomarkers
  • CAR T-cell therapy
  • Advanced mass spectrometry
  • Improving infectious disease diagnosis: NGS and syndromic approaches

Benefits of attending:

  • Review the role of CRISPR and digitalisation in the medical laboratory for enhanced diagnostic efficacy and appraise the potential and pitfalls 
  • Explore the latest updates in mass spectrometry and discuss how disease diagnosis can be improved through employing syndromic approaches and next generational sequencing
  • Identify the challenges and potential for the use of stem cells in therapeutic treatment
  • Discover innovative technologies set to rapidly transform the medical laboratory and discuss how to effectively implement these within your laboratory 

Chair:

Dr P. K EMenon, Director, Medical Office, Pure Health, Dubai, UAE

Supreet Singh Manchanda
, Managing General Partner, Raiven Capital, San Francisco, California, USA

Activity director:

Dr Fadi W. Abdul-Karim, Professor Emeritus, Cleveland Clinic Lerner School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Speaker Faculty:

Dr Ani Atanasova, CEO, pixelhunters, Dubai, UAE

Dr Baher Al Hakim, CEO, Medicus AI, Vienna, Austria

Prof Dr Brad S Karon, Professor of Laboratory Medicine and Pathology, Chair, Division ofClinical Core Laboratory Services, Mayo Clinic, Rochester, USA

Dr Eric Glassy, Board of Governor and Trustee, College of American Pathologists, Los Angeles, USA

Dr Hisham Abdel-Azim, Director of BMT Fellowship Program, Attending Physician; Hematology, Oncology and Blood and Marrow Transplantation, Investigator, Hematology-Oncology, Associate Professor of Pediatrics, Keck School of Medicine of USC, Los Angeles, California, USA

Dr Igor Kozakromesh, Clinical Lead/Medical Director, Consultant Ophthalmologist, Specialist in Vitreoretinal Surgery, Medical Retina and Uveitis, Moorfields Eye Hospital Centre, Abu Dhabi, UAE

Dr Maliha Hashmi, Executive Director, Health & Wellbeing, NEOM, Riyadh, KSA

Dr Nagib Yordi, Board Certified in Genetics and Genomics, American Board of Medical Genetics and Genomics, Consultant Orthopedic Surgery, Head of Department of Orthopedics and Sports Medicine, Healthpoint, Abu Dhabi, UAE

Dr Nagib Yordi, Board Certified in Genetics and Genomics, American Board of Medical Genetics and Genomics, Consultant
Orthopedic Surgery, Head of Department of Orthopedics and Sports Medicine, Healthpoint, Abu Dhabi, UAE

Dr Ravi Kumar Banda, Medical Scientist-Technologist, Founder, XCyton, India

Dr Tarek El-Sawy, Adjunct Clinical Assistant Professor, Stanford University, California, USA

Prof Ricardo Pais, Data Scientist, MAPSciences, Lisbon, Portugal